The caspases are a unique family of cysteine proteases, which cleave proteins next to an aspartate residue. Among all known mammalian proteases, only the serine protease granzyme B has similar substrate specificity. In addition to a central role of caspases in the initiation and execution phases of apoptosis, these enzymes have some other non-apoptotic functions in living cells. During apoptosis, upon activation, caspases cleave specific substrates and thereby mediate many of the typical biochemical and morphological changes in apoptotic cells, such as cell shrinkage, chromatin condensation, DNA fragmentation and plasma-membrane blebbing. Thus, detection of activated caspases can be used as a biochemical marker for apoptosis induced by diverse stimuli in many types of cells.
Introduction
At the end of the 1980s a novel mammalian protease, ICE (interleukin-1␤-converting enzyme; referred to as caspase-1), was identified and has been shown to play an important role in inflammation. Several years later Robert Horvitz's group reported that ICE is related to a Caenorhabditis elegans death gene product, CED-3 [1] . This seminal observation suggested that the molecular mechanisms of cell death might be highly conserved and that cysteine proteases might be essential for the regulation of the cell-death process. Since 1993 a family of related proteases has been described. This family, termed the caspases (for cysteinyl aspartate-specific proteases), indeed has been shown to play a central role in initiation and execution of apoptosis [2] . The importance of caspases for the apoptotic process was documented by several findings; (i) over-expression of caspases efficiently kills cells; (ii) synthetic or natural inhibitors of caspases effectively inhibit apoptosis induced by diverse stimuli; and (iii) knock-out animals lacking certain caspases show profound defects in apoptosis. Given the important role of this family in cell death, it is not surprising to find that these proteins might have some other functions. Indeed, non-apoptotic functions of caspases have also been described. Thus caspases are involved in the processing of cytokines during inflammation, in proliferation of T-lymphocytes as well as in terminal differentiation of lens epithelial cells and keratinocytes (for a review see [3] ). It is important to note that the role of caspases in normal cellular processes as well as in apoptosis is complex in that the caspases may have redundant functions. Moreover, the extent and kinetics of caspase activation are dependent on both the apoptotic stimuli and the cell type.
Structural and functional organization of caspases
The caspase family of proteases consists of at least 14 mammalian members. Except caspase-11 (mouse), caspase-12 (mouse) and caspase-13 (bovine), all other enzymes are of human origin ( Figure 1) . A phylogenic analysis revealed that the gene family is composed of two major subfamilies, which are related to either caspase-1 (ICE) or the mammalian homologues of CED-3 [4, 5] . Although over-expression of almost all caspases kills cells, the majority of proteins belonging to the caspase-1 subfamily are involved in processing of cytokines. In contrast, proteins from CED-3 subfamily appear to be involved primarily in cell death. Based on sequence similarities, CED-3 subfamily can be further subdivided into two groups, namely the caspase-3 and caspase-2 subfamilies. Caspases are constitutively expressed in the majority of investigated cell types as inactive pro-enzymes (zymogens) that become proteolytically processed and activated in response to a variety of proapoptotic stimuli (Figure 2 ). The pro-caspases (32-56 kDa) contain several domains: an N-terminal pro-domain, a large subunit (17-21 kDa) and a small subunit (10-13 kDa); some proteins also have a short linker region between the large and small subunits [6] . Caspase activation involves proteolytic processing of the pro-enzyme at a specific aspartic acid residue site between the large and small subunits, and in many cases, pro-domains are proteolytically removed. The active site is formed by a heterodimer containing one large and one small subunit, and the fully active caspase is a tetramer composed of two such heterodimers ( Figure 2 ).
Based on the size of pro-domains, pro-caspases can also be subdivided into two groups: those with short pro-domains (less than 30 amino acids) and those with long pro-domains (more than 100 amino acids). Pro-caspases 3, 6 and 7 contain short pro-domains and the remaining caspases have long prodomains. All caspases with short pro-domains fulfil the role of effector enzymes. Although pro-caspase-14 also belongs to the short-pro-domain caspases, this enzyme does not participate directly in the apoptotic cascade. Its activity has been implicated in the specific form of programmed cell death in the skin [7] ; however, the molecular mechanism of pro-caspase-14 maturation is unknown. The rest of the enzymes from the CED-3 subfamily are known as initiator caspases in the apoptotic process.
All caspases share two important characteristics. First, the caspases are cysteine proteases containing a conserved QACXG pentapeptide, which contains the active-site cysteine. Second, these enzymes have a unique and strong preference for cleavage of the peptide bond C-terminal to aspartic acid residues. This primary cleavage specificity makes this family very rare among protease families. Of all known mammalian proteases, only the serine protease granzyme B has similar substrate specificity. Despite the requirement for aspartate at the substrate P1 site, the caspases differ in substrate specificity and can be divided into three subgroups based on preferred tetrapeptide sequences (P4-P1). The P4 site (four amino acids N-terminal to the cleavage site) is the most critical determinant of substrate specificity [8] . Caspases in group I (caspases 1, 4, 5 and 13) cleave preferentially after the (W/L)EHD motif, group II (caspases 3 and 7) after DEXD, whereas the optimal cleavage sequences for caspases belonging to group III (caspases 6, 8, 9 and 10) are (I/L/V)EXD. Only caspase-2 preferentially cleaves after the pentapeptide sequence VDVAD (Figure 2 ). The cleavage sites for caspases 11, 12 and 14 are not yet clear.
Activation of pro-caspases
Evidence for the sequential activation of caspases has led to the concept of a caspase cascade. This cascade begins with autocatalytic activation of initiator caspases that in turn transmit the signal by cleaving and thereby activating the downstream effector caspases [9] . As mentioned above, the initiator caspases (pro-caspases 2, 8, 9, 10 and 12), as well as the so-called inflammatory The pro-caspases contain four domains: an N-terminal pro-domain, a large subunit, a small subunit and a short linker region between the large and small subunits. The active caspase is a tetramer composed of two large and two small subunits. Based on the size of pro-domains, procaspases can be subdivided into two groups: initiator and effector caspases. The caspases recognize a core tetrapeptide motif. Using a positional-scanning combinatorial substrate library it was possible to divide caspases into three groups with distinct cleavage specificity. caspases (pro-caspases 1, 4, 5, 11 and 13), contain long pro-domains, while the pro-domains in effector caspases (pro-caspases 3, 6 and 7) are short. The long pro-domains contain distinct motifs, including DEDs (death effector domains) present in pro-caspases 8 and 10 and CARDs (caspase-recruitment domains) found in pro-caspases 1, 2, 4, 5 and 9, which are important for the activation of these enzymes [10] . Activation of caspases containing long prodomains first requires oligomerization via DED or CARD domains. Following the recruitment of a single type of caspase pro-enzyme to a common oligomerization site, the low level of endogenous catalytic activity that is present in pro-enzymes is sufficient to initiate full catalytic activation by proteolysis next to the aspartic acid residue that is present at the junction between the large and small subunits ( Figures 2 and 3 ). It is likely that prodomain structure, rather than substrate specificity, determines the ability of pro-caspases to be activated by oligomerization. Active initiator caspases transmit the proteolytic signal by directly processing executioner, short-prodomain-containing pro-caspases. This first cleavage by pre-existing active caspases is followed by autoproteolysis mediated by the low level of endogenous catalytic activity that is present in these effector pro-enzymes. It has been suggested that caspases can, in principle, undergo autocatalytic activation. However, the clear evidence for a non-recruitment type of autoactivation has not been presented. There are two main intracellular pathways by which caspases can be activated; namely dependent on the ligation of death receptors or the release of apoptogenic factors from mitochondria (for a detailed review on apoptotic signalling, see [10, 11] ). Thus ligation of the TNF (tumour necrosis factor) or Fas/Apo-1/CD95 receptors results in the assembly of the so-called DISC (death-inducing signalling complex). Pro-caspase-8 via interaction with its DEDs is recruited to the DISC and becomes activated. In so-called type I cells, active caspase-8 cleaves and thereby activates pro-caspase-3, giving rise to the proteolytic cascade ( Figure 4 ). In type II cells, caspase-8 cleaves the cytosolic protein Bid and its truncated form tBid translocates to mitochondria and induces the release of cytochrome c. It is important to note that caspase-8- In all cases translocation of tBid to the mitochondria was observed and was followed by the release of cytochrome c from the intermembrane space of mitochondria. Interestingly, in some experimental models calpain can also cleave caspases, and most often this cleavage inactivates caspase function. For example, calpain can cleave caspase-7 at sites distinct from those cleaved by the upstream caspases, generating proteolytically inactive fragments. Procaspases 8 and 9 can also be cleaved by calpains, and truncated caspase-9 is unable to activate pro-caspase-3. Finally, it has been reported that pro-caspase-3 cleavage by calpain results in the generation of a 29-kDa fragment, although it is unclear whether such cleavage causes the activation or inactivation of caspase-3 function ( Figure 4 ). The best-known example of caspase activation by calpain is the cleavage of mouse pro-caspase-12, although the precise mechanism of this activation is unclear [12] .
In most other apoptotic models, the caspases are activated downstream of mitochondrial release of cytochrome c. Upon entering the cytosol, cytochrome c binds to Apaf-1 (apoptotic protease-activating factor 1), which oligomerizes in the presence of dATP/ATP and binds pro-caspase-9 to form the so-called apoptosome complex [10] . This leads subsequently to autoproteolysis and activation of pro-caspase-9. In this scenario, again the activated initiator caspase 
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Calpain DNA damage (caspase-9), similar to caspase-8, propagates the death signal by proteolytically processing and activating downstream-located effector caspases (Figure 4 ).
Caspase-2 was one of the first mammalian apoptotic caspases to be identified [13] and its activity was implicated in cell death. However, the precise function of this enzyme in apoptosis was unclear. Recently, it has been shown that caspase-2 is required for DNA-damage-induced apoptosis [14] . It is the only pro-caspase that is present constitutively in the nucleus as well as in the Golgi apparatus. In response to DNA damage, activation of this enzyme was observed upstream of pro-caspase-9, indicating that caspase-2 acts as an effector of the mitochondrial pathway. Although the mechanism of pro-caspase-2 activation is unclear, the proposed model suggested that active caspase-2, or more likely a cleaved substrate, translocates out of the nucleus to target mitochondria and stimulates cytochrome c release. In this case, mitochondria may act as an amplifier rather than an initiator of caspase activity ( Figure 4 ).
Intracellular inhibitors of caspase activity
A processed caspase is not necessarily catalytically active since processing and activation are under control of different protein factors, such as FADD (Fasassociated death domain) and Apaf-1, inhibitor proteins [FLIP (Flice-like inhibitory protein), IAPs (inhibitors of apoptosis protein) and Bcl-2-like proteins], HSPs (heat-shock proteins) and viral proteins [crmA, p35, vMIA (viral mitochondria-localized inhibitor of apoptosis)]. IAPs are a family of proteins that bind and inhibit caspases directly [15] . Studies have indicated that, unlike other caspases, pro-caspase-9 processing was necessary, but not sufficient, for catalytic activity [16] . Caspase-9 in complex with Apaf-1 seems to represent the active form of caspase-9. Thus Apaf-1 may not simply be an activator of caspase-9, but rather an essential regulatory subunit of the caspase-9 holoenzyme. Recruitment of pro-caspase-9 into the apoptosome complex and its activation are in addition controlled by HSPs and IAPs [17, 18] . Activity of caspases is also controlled by several proteins, such as IAPs, crmA and HSPs. Recently, it has been shown that NO inhibits activity of at least seven caspases via nitrosation of the catalytic cysteine residue. In these experiments, in vitro caspase activity can be restored in the presence of dithiothreitol [19] . Interestingly, NO donors might also act directly at the level of the apoptosome and inhibit the sequential activation of caspases 9, 3 and 8 [20] .
It has been suggested that Akt, a kinase that suppresses apoptosis, phosphorylates caspase-9, thereby preventing activation of this protease [21] . Despite the close similarity between human and mouse caspase-9, the latter does not contain an Akt phosphorylation site. The authors suggested that in mouse cells an additional evolutionarily conserved mechanism exists by which Akt can suppress activation of caspases in the mitochondrion-mediated pathway [21] . However, to prove this hypothesis, several critical experiments should be performed.
The caspases themselves are cysteine-dependent enzymes and, as such, appear to be redox-sensitive. One of the most reproducible inducers of caspase-mediated apoptosis is mild oxidative stress, although it is unclear how an oxidative stimulus can directly activate the caspase cascade. On the other hand, experiments with H 2 O 2 suggested that prolonged or excessive oxidative stress can actually prevent caspase activation. A physiological example of this is the NADPH oxidase-derived oxidants generated by stimulated neutrophils that prevent caspase activation in these cells [22] .
There are some indications for the possible role of ubiquitination in regulation of caspase activity; however, additional experiments are required to understand the significance of this observation.
Consequences of caspase activation during apoptosis
The pro-caspases are found in multiple intracellular compartments, including mitochondria, endoplasmic reticulum, Golgi apparatus, cytosol and nucleus, and the subcellular localization of the pro-enzyme is often different from the scene of action of the activated caspase. Several caspases, after being activated, translocate to other intracellular compartments, such as the endoplasmic reticulum and nucleus, where they cleave specific target proteins [23] . It is clear that if the proteolysis of substrate contributes functionally to the demise of the cell, this substrate should be cleaved prior to the biochemical and morphological manifestations of apoptotic cell death. In line with this hypothesis, caspase-mediated cleavage deregulates the activity of its cellular target prior to morphological changes ( Figure 5) .
Presently, more than 200 caspase substrates are known and the list continues to grow [24] . This list includes proteins, which carry out different functions. Among these proteins are structural proteins, signalling proteins, regulators of transcription and translation, regulators of replication and cell cycle, regulators of DNA repair and cleavage, regulators of RNA metabolism, regulators of cell-cell interaction, regulators of pro-inflammatory cytokines, regulators of apoptosis and many others. Thus caspase-mediated cleavage can result in either inactivation (in most cases) of proteins essential for the cell's structural integrity or survival, or activation of dormant, proapoptotic proteins. Among the proteins that are inactivated by cleavage are cytoskeletal proteins, including lamin, ␣-fodrin and actin, and proteins involved in DNA repair and cell-cycle regulation, such as PARP (polyADPribose polymerase) and retinoblastoma protein, respectively. In addition to the pro-caspases themselves, caspase substrates that are activated upon cleavage of an inhibitory domain include protein kinase C␦ and transcription factor sterol regulatory element-binding proteins. The CAD (caspaseactivated DNase) is indirectly activated by cleavage of an inhibitory subunit, ICAD (inhibitor of CAD). This caspase-mediated cleavage results in release and activation of the catalytic subunit of CAD ( Figure 6 ).
Although caspases do not contain a nuclear localization signal, many of these enzymes are translocated into the nuclei of apoptotic cells [25] . Numerous nuclear-located proteins are cleaved by different caspases, suggesting that caspase translocation into the nucleus is an important event during apoptosis ( Figure 6 ).
Figure 6. Role of caspases in nuclear apoptosis
Translocation of active caspases into the nucleus results in cleavage of many nuclear proteins, which leads to DNA fragmentation, chromatin margination and nuclear collapse. CAD, caspaseactivated DNase; ICAD, inhibitor of CAD; AP-2␣, activator protein-2␣; SATB1, special AT-rich sequence-binding protein 1. RAD, protein involved in homologous recombination and DNA repair; RFC, replication factor C; DNA-PK, DNA-dependent protein kinase. Caspase-3 is activated during most apoptotic processes and is believed to be the main executioner caspase. The presence of active caspase-3 in the nucleus is essential for cleavage of different proteins, for DNA fragmentation and chromatin condensation. Caspase-7 cleaves PARP and some other nuclear proteins in vitro; however, clear evidence for its activity in the nuclei of apoptotic cells is still absent. Caspase-6 has been shown by many groups to cleave lamin. However, in casp-6-null cells and in casp-6-knockout mice, the cleavage of lamin was observed in response to diverse stimuli [26] . In addition to lamin, caspase-6 cleaves several nuclear proteins, such as transcription factor activator protein-2␣, SATB1 (special AT-rich sequence-binding protein 1) and the viral nucleocapsid protein of transmissible gastroenteritis coronavirus. Interestingly, experiments using cell-free extracts immuno-depleted of caspase-3, -6 or -7 have shown that depletion of caspase-3 results in the absence of cleavage of a majority of nuclear substrates as well as DNA fragmentation, chromatin marginization and nuclear collapse [27] . However, although caspases 6 and 7 are considered to be important downstream effector caspases, depletion of either caspase had minimal impact on any of the nuclear parameters investigated, raising questions concerning their precise role during the execution step of apoptosis within the nucleus, at least in cell-free extracts. Although active caspases 2 and 9 were detected in the nuclei of apoptotic cells, their precise targets within this intracellular compartment are unknown.
Even though caspase-independent cell death exists, most experimental models of apoptosis involve the activation of caspases. Until now, no activation of caspases has been found during necrotic cell death. Moreover, inactivation of caspases might switch the death process from apoptosis to necrosis. Therefore, the detection of activated caspases can be used as a biochemical marker of apoptosis induced by diverse stimuli in many types of cells.
Methods for analysis of caspase identification or activation
Detection and identification of different caspases was performed using twodimensional PAGE [28] . In two-dimensional PAGE, proteins are separated according to their isoelectric point and size. Since the various caspases have different isoelectric points and sizes, they will appear in different areas on the two-dimensional gel.
Determination of caspase activation can be performed in different ways and the advantages and disadvantages of each technique were outlined recently [29] .
Detection of activated caspases by immunoblotting
As mentioned above, pro-caspases are proteolytically cleaved to become active enzymes. This processing of a particular pro-caspase can be studied by using the immunoblot technique. The appearance of the small or large subunit of a mature caspase can be detected with a specific antibody. The cleavage of a pro-caspase with the appearance of large and small subunits can be used as a marker for processing/activation of the specific caspase. However, as discussed above, the processed caspase is not necessarily activated. Therefore, to confirm that processed caspases are also catalytically active, additional studies on enzymic activity using synthetic peptides or known caspase target proteins might be performed.
Cleavage of synthetic substrates
One of the commonly used ways to detect caspase activity is to measure the cleavage of synthetic substrates upon their incubation with lysates of apoptotic cells. The principle of this technique was described several years ago [30] . Substrates containing tetrapeptide sequences mimicking the cleavage sites of the various caspase subgroups have been synthesized and are now commercially available. The tetrapeptides are conjugated to either the chromophore p-nitroanilide or a fluorochrome, such as 7-amino-4-methylcoumarin or 7-amino-4-trifluoromethyl coumarin. Upon cleavage of the substrate, the liberated chromophore p-nitroanilide or fluorophores 7-amino-4-methylcoumarin and 7-amino-4-trifluoromethyl coumarin are analysed by spectrometry or fluorometry, respectively. This method can be performed using whole-cell extracts, complex mixtures or purified caspases.
To determine the activity of a specific caspase and not a subgroup of caspases, a fluorometric immunosorbent enzyme assay has been developed. In this assay the caspase of interest is captured from cell lysates using a monoclonal antibody. After washing, the tetrapeptide substrate is added and the caspase activity is measured as described above.
Caspase inhibitors and affinity labelling
Caspase inhibitors can be used to determine the importance of caspases for apoptotic cell death in general or for a certain apoptotic event in particular. In systems where the activation of caspases is crucial for apoptosis to occur, the inhibitors block or at least delay cell death. Caspase inhibitors act by binding to the active site of caspases and form either a reversible or an irreversible linkage. Many of the irreversible inhibitors function by forming covalent adducts with the cysteine in the active site of the caspase [7] . Peptide inhibitors that have preferences for specific caspases, or caspase subgroups, include a caspaserecognition sequence (often the same as the preferred tetrapeptide sequence for substrate cleavage) conjugated to a functional group such as an aldehyde, chloromethylketone, FMK (fluoromethylketone) or fluoroacyloxymethylketone. Caspase inhibitors with an aldehyde group are reversible and those with chloromethylketone, FMK or fluoroacyloxymethylketone groups are irreversible inhibitors. To determine the activation of a particular caspase, a specific inhibitor, such as biotinylated N-acetyl-Asp-DEVD-aldehyde, can be employed that preferentially labels active caspase-3-like proteases.
The ELISA is another method that can be recommended for determination of the activation of a specific caspase when using biotin-labelled inhibitors. After incubation with a biotinylated inhibitor, which labels active caspases in a sample, a specific antibody is added in order to capture the caspase of interest. The antibody-bound caspase is then detected with horseradish peroxidase-conjugated streptavidin that binds to biotin. Although the antibody captures both active and latent enzyme, the biotinylated inhibitor binds only to the active enzyme and the two are thereby distinguished.
Detection of cleavage of caspase substrates by immunoblotting
Many proteins are specifically cleaved by caspases during the apoptotic process. Hence, the identification of these protein fragments allows one to judge indirectly the activation of caspases. The proteins in a sample are resolved by SDS/PAGE and transferred to a membrane by the immunoblot procedure. Many antibodies that can be used for detection of cellular caspase substrates by this technique are commercially available.
Activation of caspases in intact cells investigated by confocal or fluorescence microscopy and/or flow cytometry
The activation of caspases can also be detected in whole cells using several approaches. PhiPhiLux is a cell-permeable fluorogenic caspase substrate that can be used to detect and measure the activation of caspases in cells. PhiPhiLux contains the amino acid sequence DEVDGI that is recognized and cleaved by caspase-3-like enzymes (caspases in subgroup II). In addition to the caspaserecognition motif, the substrate contains two rhodamines (which fluoresce green) or rhodamine derivatives (which fluoresce red). The fluorescence is quenched in the non-cleaved substrate, but not in the cleaved ones. Hence, the fluorescence observed in cells incubated with the substrate corresponds to the activity of caspases belonging to subgroup II and can be detected by flow cytometry or fluorescence microscopy.
Activation of caspases in intact cells can also be assayed by immunohistochemistry using antibodies against either the active caspase or any caspasecleaved products. The primary antibody as well as a secondary antibody can be conjugated to a fluorescent probe, such as FITC (fluorescein isothiocyanate). In this situation, the stained cells can be analysed by flow cytometry and by fluorescent or laser scanning confocal microscopy.
Proteins cleaved by caspases can also be detected using immunohistochemistry. For instance, antibodies against cleaved PARP, actin and cytokeratin 18 have been used extensively for this purpose. In addition to tissue sections, immunostaining can also be performed in the analysis of cultured cells (immunocytochemistry). Adherent cells can be cultured directly on coverslips and cells growing in suspension can be sedimented on to a coverslip using the cytospin technique.
Recently, a new approach using recombinant caspase substrates for monitoring caspase activity in vivo has been developed [31] . The substrate contained tandem repeats of GFP (green fluorescent protein) separated by DEVD or other cleavage sites. Cells were transfected with a vector containing the gene encoding the substrate using a tetracycline-inducible expression system. The expressed caspase substrate was cleaved upon apoptosis induction. Cleavage of the substrate releases GFP and this prevents the fluorescence resonance energy transfer, which is a phenomenon that occurs when two fluorophores with overlapping emission and excitation spectra, such as GFP, are physically close to each other [32] . The increase in fluorescence upon cleavage of the caspase substrate can be detected using a fluorimeter or flow cytometer as well as with fluorescent or laser-scanning confocal microscopes.
CaspaTags and FLICAs (fluorochrome-labelled inhibitors of caspases) are newly developed types of fluorescent probe suggested for use in the detection of activated caspases in living cells. These compounds are carboxyfluoresceinlabelled FMK inhibitors, which are cell-permeant and should bind irreversibly to the active site of individual caspases (containing the caspase-recognition sequence for each caspase separately) or to all caspases (containing the amino acid sequence VAD) [33] . It has been shown that CaspaTags and FLICAs exclusively stain cells containing the processed caspases of interest and the probes do not accumulate in normal (non-apoptotic) cells. Therefore, apoptotic cells containing active caspases should be identified and distinguished from non-apoptotic cells by their fluorescence using flow cytometry, fluorescence microscopy or a fluorescence microtitre plate reader. However, prior to the publication of this volume, additional control experiments were performed by the authors and results have shown that a predominant component in the binding of these reagents to apoptotic cells does not reflect their direct reactivity with the protease's active centres. Moreover, the bulk portion of fluorochrome-tagged protease inhibitors that react with apoptotic cells bind to sites other than the active enzyme centres of the respective enzymes (Z. Darzynkiewicz, G. Jahnson and B.W. Lee, personal communication submitted for distribution via the International Cell Death Society). Thus the labelling of apoptotic cells with these reagents is not a specific marker of caspase activation and therefore should be taken into consideration.
Given the critical importance of caspases in the realization of the apoptotic process, development of new more sensitive methods of measurement of caspase activity in vivo has remained high on the wish list of apoptosis researchers.
Conclusions
Activation of caspase family proteases has been detected in numerous cell systems and appears to function as a pathway through which apoptotic mechanisms operate. Our understanding of caspase activation and effector function has been greatly enhanced during the last 10 years; however, a lot of ground still remains to be covered. For example, the precise role of several caspases in cell death, as well as mechanisms of their activation or regulation of their function is still unclear. The functional significance of the majority of cleaved caspase substrates also remains to be determined. Since inappropriate apoptosis is clearly associated with the aetiology of several human diseases [34] and the role of caspase in the regulation of cell death has been well documented, the manipulation of caspase activation/activity might be an important key in the treatment of these diseases. 
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